×

Q4 2024 Or 2024 Q4 Results

Q4 2024 Or 2024 Q4 Results

Q4 2024 Or 2024 Q4 Results. Aurobindo pharma ltd (bom:524804) q4 2024 earnings call transcript highlights: Today announced the following results for the fiscal year ended june 30, 2024, as compared to the corresponding period of last fiscal year:


Q4 2024 Or 2024 Q4 Results

Mint’s quarterly results calendar page is a hub of that essential. Investors will be looking at the performance of players like varun beverages, zomato, jindal steel & power, aditya birla capital, chalet.

Q4 2024 Or 2024 Q4 Results Images References :

You May Have Missed